Company Analysis

Tonix Pharmaceuticals Holding Corp. (TNXP)

Nasdaq: TNXP · Pharmaceutical Preparations · Berkeley Heights, NJ · filing with the SEC since 2008
Grade4.6
◀ Past 3.4● Present 5.3▶ Future 4.6
2 est.

Filings

834 filings since 2017 beside 205 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 40 days after the quarter ended. The proxy statement was last filed Mar 30, 2026.

Filings a yearinsider forms included
120136102981191189568
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Aug 18, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest Mar 18, 2026.Listing warning from its exchange (8-K item 3.01): 1 time in the last 36 months, the newest Aug 9, 2024.SEC letters: 6 in the last 36 months, the newest Sep 3, 2025.A late-filing notice, Form NT 10-Q, filed Aug 15, 2024.
Insider forms 205

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 13, 2026 SCHEDULE 13G/A Large holder update, amended
Nov 9, 2026 10-Q Quarterly report Sep 30, 2026
Nov 9, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 15, 2026 8-K items 2.02, 8.01 Results released; Other event · Current report
Oct 2, 2026 8-K item 8.01 Other event · Current report Oct 1, 2026
Sep 22, 2026 8-K items 8.01, 9.01 Other event · Current report
Sep 8, 2026 8-K items 8.01, 9.01 Other event · Current report
Aug 18, 2026 8-K items 5.02, 8.01 Officer or director change; Other event · Current report
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 13, 2026 SCHEDULE 13G Large holder notice
Aug 10, 2026 10-Q Quarterly report Jun 30, 2026
Aug 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 3, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jul 21, 2026 8-K item 5.02 Officer or director change · Current report Jul 20, 2026
Jul 13, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jul 1, 2026 S-8 Employee stock plan registration
Jun 29, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Jun 15, 2026 SCHEDULE 13G Large holder notice
Jun 8, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 27, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 15, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 15, 2026 SCHEDULE 13G Large holder notice
May 11, 2026 8-K items 2.02, 9.01 Results released · Current report
May 11, 2026 10-Q Quarterly report Mar 31, 2026
May 7, 2026 8-K items 5.02, 5.07, 9.01 Officer or director change; Shareholder vote · Current report
May 6, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 1, 2026 8-K items 2.02, 8.01 Results released; Other event · Current report
Apr 29, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Apr 23, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Apr 21, 2026
Mar 31, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report Mar 30, 2026
Mar 30, 2026 DEF 14A Proxy statement May 7, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 26, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Mar 20, 2026 PRE 14A Preliminary proxy statement May 7, 2026
Mar 18, 2026 8-K items 4.01, 9.01 Auditor change · Current report Mar 16, 2026
Mar 13, 2026 ARS Annual report to shareholders Dec 31, 2025
Mar 13, 2026 8-K items 2.02, 9.01 Results released · Current report Mar 12, 2026
Mar 12, 2026 10-K Annual report Dec 31, 2025
Mar 10, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
40 of 834 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TNXP · research, not advice